Status | Study |
Completed |
Study Name: Oral Peanut Immunotherapy for Peanut Allergic Patients Condition: Peanut Hypersensitivity Date: 2013-05-24 Interventions: Drug: Peanut protein Subjects will receive increasing amounts of peanut protein over the modified rush p |
Active, not recruiting |
Study Name: Peanut Oral Immunotherapy in Children Condition: Peanut Hypersensitivity Date: 2013-05-23 Interventions: Biological: Peanut Oral Immunotherapy - Liquid Extract |
Completed |
Study Name: Efficacy and Safety of Several Doses of Viaskin Peanut in Adults and Children With Peanut Allergy Condition: Peanut Allergy Date: 2012-08-17 Interventions: Biological: Viaskin Peanut 50 mcg |
Completed |
Study Name: Pilot Study to Evaluate the Effect of Ketotifen on the Adverse Events Associated With Peanut Desensitization Condition: Peanut Allergies in Children Date: 2012-06-19 Interventions: Drug: Ketotifen titrated dose: 1 mg once a day, then 1 mg twice a day then 2 mg twice a day |
Withdrawn |
Study Name: Efficacy and Safety of 4 Doses of QGE031 in Patients 18-50 Years of Age With Peanut Allergy Condition: Peanut Allergy Date: 2011-10-10 Interventions: Drug: QGE031 QGE031 liquid for |
Active, not recruiting |
Study Name: The Effect of Extrinsic Factors on Food Allergy Condition: Peanut Hypersensitivity Date: 2011-08-31 Interventions: Other: Food challenge Double blind placebo controlled peanut challenge. Each challenge given with or wit |
Withdrawn |
Study Name: Peanut Allergy Oral Immunotherapy Desensitization Condition: Peanut Allergy Date: 2011-07-27 Interventions: Procedure: Peanut protein 500 |
Completed |
Study Name: Epicutaneous Immunotherapy in Peanut Allergy in Children Condition: Peanut Allergy Date: 2010-09-07 Interventions: Biological: Epicutaneous Immunotherapy |
Active, not recruiting |
Study Name: Oral Peanut Immunotherapy Condition: Peanut Allergy Date: 2010-08-12 Interventions: Drug: Peanut flour OIT Patients will receive daily escalating dosages as determined in the modified rush |
Completed |
Study Name: Safety of Epicutaneous Immunotherapy for the Treatment of Peanut Allergy Condition: Peanut Allergy Date: 2010-07-24 Interventions: Biological: Whole peanut extract |